Literature DB >> 16620194

The case for disease management in chronic kidney disease.

Randolph A Chen1, Susan Scott, William D Mattern, Ravinder Mohini, Allen R Nissenson.   

Abstract

Chronic kidney disease (CKD) is a growing epidemic in the United States and worldwide, with nearly two thirds of CKD patients also having diabetes, hypertension, or both. Morbidity and mortality among patients with CKD are high, as are the costs associated with care, which is highly fragmented. Disease management (DM) programs are designed to coordinate the delivery of care to patients, improve clinical outcomes, and reduce costs along the continuum of care. The goals of DM programs in CKD patients are to fill the gaps in current care by focusing on four key areas: (1) slowing the progression of CKD, (2) identifying and managing the complications of CKD, (3) identifying and managing associated comorbid conditions, and (4) smoothing the transition to renal replacement therapy (RRT). To be successful, this approach requires multidisciplinary collaboration among physicians (eg, primary care physicians, endocrinologists, cardiologists, nephrologists, surgeons) and participating caregivers including nurses, dieticians, social workers, and pharmacists. Patient identification, limited reimbursement, late patient referral, and lack of primary care physician and nephrologist knowledge about the importance and details of CKD management are all barriers that must be overcome for such programs to be successfully implemented. Considering the magnitude of the opportunity, DM applied to CKD is a promising approach to the care of this vulnerable population.

Entities:  

Mesh:

Year:  2006        PMID: 16620194     DOI: 10.1089/dis.2006.9.86

Source DB:  PubMed          Journal:  Dis Manag        ISSN: 1093-507X


  9 in total

1.  Evaluation of the impact of pharmaceutical care service on hospitalized patients with chronic kidney disease in Jordan.

Authors:  Salah M AbuRuz; Yazan Alrashdan; Anan Jarab; Deema Jaber; Izzat A Alawwa
Journal:  Int J Clin Pharm       Date:  2013-07-25

Review 2.  Early chronic kidney disease: diagnosis, management and models of care.

Authors:  Olivier J Wouters; Donal J O'Donoghue; James Ritchie; Panos G Kanavos; Andrew S Narva
Journal:  Nat Rev Nephrol       Date:  2015-06-09       Impact factor: 28.314

3.  Red blood cell distribution width at admission predicts outcome in critically ill patients with kidney failure: a retrospective cohort study based on the MIMIC-IV database.

Authors:  Rongqian Hua; Xuefang Liu; Enwu Yuan
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

4.  Challenges perceived by primary care providers to educating patients about chronic kidney disease.

Authors:  Raquel C Greer; Deidra C Crews; L Ebony Boulware
Journal:  J Ren Care       Date:  2012-12

5.  Nephron-deficient Fvb mice develop rapidly progressive renal failure and heavy albuminuria involving excess glomerular GLUT1 and VEGF.

Authors:  Youli Wang; Kathleen O Heilig; Andrew W Minto; Shenglin Chen; Minghui Xiang; David A Dean; Richard C Geiger; Anthony Chang; Dimitrina D Pravtcheva; Martin Schlimme; Dilip K Deb; Ying Wang; Charles W Heilig
Journal:  Lab Invest       Date:  2009-11-16       Impact factor: 5.662

6.  Predictors of Out-of-ACO Care in the Medicare Shared Savings Program.

Authors:  Maria A Han; Robin Clarke; Susan L Ettner; William Neil Steers; Mei Leng; Carol M Mangione
Journal:  Med Care       Date:  2016-07       Impact factor: 2.983

7.  Explore Transplant at Home: a randomized control trial of an educational intervention to increase transplant knowledge for Black and White socioeconomically disadvantaged dialysis patients.

Authors:  Amy D Waterman; Anna-Michelle M McSorley; John D Peipert; Christina J Goalby; Leanne J Peace; Patricia A Lutz; Jessica L Thein
Journal:  BMC Nephrol       Date:  2015-08-28       Impact factor: 2.388

8.  Assessment of serum electrolytes and kidney function test for screening of chronic kidney disease among Ethiopian Public Health Institute staff members, Addis Ababa, Ethiopia.

Authors:  Meseret Derbew Molla; Maria Degef; Abebe Bekele; Zeleke Geto; Feyissa Challa; Tadesse Lejisa; Tigist Getahun; Meron Sileshi; Yosef Tolcha; Genet Ashebir; Daniel Seifu
Journal:  BMC Nephrol       Date:  2020-11-18       Impact factor: 2.388

9.  Mesenchymal Stem Cells Attenuate Renal Fibrosis via Exosomes-Mediated Delivery of microRNA Let-7i-5p Antagomir.

Authors:  Juan Jin; Fengmei Qian; Danna Zheng; Wenfang He; Jianguang Gong; Qiang He
Journal:  Int J Nanomedicine       Date:  2021-05-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.